| Patents for A61K 45 - Medicinal preparations containing active ingredients not provided for in groups (115,020) |
|---|
| 06/03/2004 | WO2004045617A1 Combination chemotherapy comprising a mek inhibitor and capecitabine for treating cancer |
| 06/03/2004 | WO2004045615A1 Palonosetron for the treatment of chemotherapy-induced emesis |
| 06/03/2004 | WO2004045612A1 Use of a proton pump inhibitor for preventing postoperative nausea and vomiting |
| 06/03/2004 | WO2004045611A1 Use of a thiazolidinedione for the reduction of side effects of chemotherapy |
| 06/03/2004 | WO2004045593A2 Combination cancer therapy with a gst-activated anticancer compound and another anticancer therapy |
| 06/03/2004 | WO2004045551A2 Pharmaceutical composition |
| 06/03/2004 | WO2004045536A2 Method and compositions for temporarily incapaciting subjets |
| 06/03/2004 | WO2004045533A2 Method and compositions for treating persistent pulmonary hypertension using aralkyl ester soft drugs |
| 06/03/2004 | WO2004045523A2 Combination administration of an indolinone with a chemotherapeutic agent for cell proliferation disorders |
| 06/03/2004 | WO2004045509A2 Method of using a cox-2 inhibitor and a 5-ht1a receptor modulator as a combination therapy |
| 06/03/2004 | WO2004045505A2 Extract of stephaniae sinica diels and methods of using the same |
| 06/03/2004 | WO2004045497A2 Cd26-based therapies for cancers and immune disease |
| 06/03/2004 | WO2004045426A1 Method and apparatus for the detection and occlusion of blood vessels |
| 06/03/2004 | WO2004035037A3 Derivatives of n-phenylanthranilic acid and 2-benzimidazolon as potassium channel and/or cortical neuron activity modulators |
| 06/03/2004 | WO2004026243A3 Therapeutic uses of linear ketophosphonates |
| 06/03/2004 | WO2004022031A3 Stable probiotic microsphere compositions and their methods of preparation |
| 06/03/2004 | WO2004013306A3 Drosophila g protein coupled receptors, nucleic acids, and methods related to the same |
| 06/03/2004 | WO2004009549A3 Piperidines useful for the treatment of central nervous system disorders |
| 06/03/2004 | WO2004006849A3 Combinations of drugs for the treatment of neoplasms |
| 06/03/2004 | WO2003106974A3 Diagnosis and treatment of chemoresistant tumors |
| 06/03/2004 | WO2003099194A3 Pharmaceutical combination of pde5 inhibitors with ace inhibitors |
| 06/03/2004 | WO2003086371A3 Use of ep4 receptor ligands in the treatment of il-6 involved diseases |
| 06/03/2004 | WO2003079025A3 Methods for the identification of compounds useful for the suppression of chronic neuropathic pain and compositions thereof |
| 06/03/2004 | WO2003057159A9 Psoriasin expression by breast epithelial cells |
| 06/03/2004 | WO2003051842A3 Compositions decreasing activity of hormone-sensitive lipase |
| 06/03/2004 | WO2003041128A3 Methods of promoting uptake and nuclear accumulation of polyamides in eukaryotic cells |
| 06/03/2004 | WO2003024481A3 Packaging of immunostimulatory substances into virus-like particles: method of preparation and use |
| 06/03/2004 | WO2002102846B1 Pharmaceutical composition for diagnosis, prevention or treatment of a tumorous state, comprising a modulator of the actin polymerisation state |
| 06/03/2004 | WO2002093998A3 Suppression of allergic reactions by transdermal administration of allergens in conjunction with or conjugated to toxin subunits or fragments thereof |
| 06/03/2004 | WO2002069950A8 Tumor treatement with a combination of a substrate of mrp5 and modulators of mrp5 |
| 06/03/2004 | US20040107453 Multipotent adult stem cells, sources thereof, methods of obtaining same, methods of differentiation thereof, methods of use thereof and cells derived thereof |
| 06/03/2004 | US20040106896 System and method for forming a non-ablative cardiac conduction block |
| 06/03/2004 | US20040106778 Interferon gamma-like protein |
| 06/03/2004 | US20040106687 Carotenoids as anti-hypertension agents |
| 06/03/2004 | US20040106675 class of compounds generally called the "statins" for use in stimulating bone formation and method to identify compounds useful in this regard by assessing their ability to inhibit enzymes in the pathway of isoprenoid synthesis |
| 06/03/2004 | US20040106668 Immunosuppressive effects of administration of a cyclooxygenase-2 inhibitor, a leukotriene B4 receptor inhibitor and a cyclosporin |
| 06/03/2004 | US20040106660 Novel pharmaceutical formulation containing a biguanide and a thiazolidinedione derivative |
| 06/03/2004 | US20040106656 Dipeptidyl peptidase inhibitors for the treatment or prevention of diabetes |
| 06/03/2004 | US20040106652 such as (2S)-3,3-dimethyl-1-[2-(5-phenylpentanoyl) pyrrolidinyl]pentane-1,2-dione which has affinity for immunophilin; for treatment of neurological disorders/neurodegenerative diseases; nerve growth factors; FK binding proteins |
| 06/03/2004 | US20040106647 Modulators of Cdk9 as a therapeutic target in cardiac hypertrophy |
| 06/03/2004 | US20040106637 detecting the presence or absence of increased S6 kinase activity in said biological sample. |
| 06/03/2004 | US20040106634 Methods for treating or preventing an inflammatory or metabolic condition or inhibiting JNK |
| 06/03/2004 | US20040106626 amidine containing compounds which inhibit serine proteases |
| 06/03/2004 | US20040106619 For prevention and/or treatment for HIV infection or AIDS induced by the infection |
| 06/03/2004 | US20040106613 For treating sickle cell disease and glaucoma. |
| 06/03/2004 | US20040106605 Synergistic methods and compositions for treating cancer |
| 06/03/2004 | US20040106604 Novel pyrrole derivatives as pharmaceutical agents |
| 06/03/2004 | US20040106601 Method of increasing neutrophil production using optically-pure (R)-2,3-benzodiazepines |
| 06/03/2004 | US20040106590 Methods and reagents for treating infections of clostridium difficile and diseases associated therewith |
| 06/03/2004 | US20040106588 Topical application of alpha-DFMO and steroid to treat Vulvar Intraepithelial Neoplasia |
| 06/03/2004 | US20040106586 Hormone replacement therapy method and its administration form |
| 06/03/2004 | US20040106584 commonly associated with atherosclerotic cardiovascular disease, coronary disease or cerebrovascular disease. |
| 06/03/2004 | US20040106582 carbo-or heterocycle-ethynyl-substituted pyridines or pyrimidines; e.g., 2-[2-(pyridine-3-yl)ethynyl]-6-methyl-pyridine |
| 06/03/2004 | US20040106575 2-Alkylated-cyclodextrin derivatives: reversal agents for drug-induced neuromuscular block |
| 06/03/2004 | US20040106572 Use of an adenosine a3 receptor agonist for inhibition of viral replication |
| 06/03/2004 | US20040106568 Nucleic acid sequences containing unmethylated CpG dinucleotides that modulate an immune response including stimulating a Th1 pattern of immune activation, cytokine production, NK lytic activity, and B cell proliferation |
| 06/03/2004 | US20040106561 comprises phytoestrogen isolated from red clover or soya, selected from genistein, daidzein, biochanin A, and/or formononetin; for treatment/prevention of cancer |
| 06/03/2004 | US20040106559 for inhibiting proteases |
| 06/03/2004 | US20040106556 solvent extraction; amyloid precursor proteins |
| 06/03/2004 | US20040106542 Compositions and methods for enhancing receptor-mediated cellular internalization |
| 06/03/2004 | US20040106540 Method of treating cancer |
| 06/03/2004 | US20040106539 Agents for the treatment of viral infections |
| 06/03/2004 | US20040106538 Regulators of PPARdelta (beta) and their use in the treatment of obesity and insulin resistance |
| 06/03/2004 | US20040106197 Central nerve system precursor cells inducing synaptogenic neurons in spinal cord |
| 06/03/2004 | US20040106196 Systems and methods for treating patients with processed lipoaspirate cells |
| 06/03/2004 | US20040106185 Oral bacteriotherapy compositions and methods |
| 06/03/2004 | US20040106160 Screening assay for antagonists of human leukocyte receptors |
| 06/03/2004 | US20040106155 Method for kidney disease treatment by drug intervention |
| 06/03/2004 | US20040106120 Identifying nucleotide sequence changes/polymorphism associated with abnormal cell adhesion and treating skin, asthma and chronic obstruction pulmonary disease using enzyme inhibitors |
| 06/03/2004 | US20040106105 Vaccine |
| 06/03/2004 | US20040105907 Anti-inflammatory effects of the partially purified extract of radix stephaniae tetrandrae |
| 06/03/2004 | US20040105896 Metal compunds, mixed or sulphated, as phosphate binders |
| 06/03/2004 | US20040105894 Trace Metals synergized copper nucleotides and copper glycosides for anti-aging and antiviral compositions |
| 06/03/2004 | US20040105865 Treatment and diagnosis of prostate cancer |
| 06/03/2004 | US20040105863 Method to search for male antifertility drugs based on PHGPx activity determination |
| 06/03/2004 | US20040105861 Use of factor XIIIa inhibitors to treat atherosclerosis |
| 06/03/2004 | US20040105857 Methods and compositions for enhancing angiogenesis |
| 06/03/2004 | US20040105850 Administering nitrosated angiotensin converting enzyme inhibitors and other nitrosated compounds for cardiovascular disorders and treatment of hypertensive agents |
| 06/03/2004 | US20040105849 spinal muscular atrophy diseases for genetic disorders treatment with vitamin c and pectins, flavonoids, enzyme supplements or enteric bacterium |
| 06/03/2004 | US20040105848 Enteric dialysis to treat renal, kidney and gastrointestinal problems andprobiotic bacteria to reduce urea |
| 06/03/2004 | US20040105838 Orlistat compositions |
| 06/03/2004 | US20040105835 hydroxpropylated starch (HPS) or hydroxylethylated starch (HES) for the use in pharmaceutical, veterinary, food, cosmetic or other products like films for wrapping food, aspics or jellies, for predosed formulations like soft or hard capsules |
| 06/03/2004 | US20040105822 Combinations of formoterol and mometasone furoate for asthma |
| 06/03/2004 | US20040103902 Condom with an erectogenic composition |
| 06/03/2004 | DE10251809A1 Medicinal drink used e.g. for treating pain or fever or preventing vascular occlusion or cancer comprises water containing dissolved acetylsalicylic acid |
| 06/03/2004 | CA2546696A1 Polymeric boronic acid derivatives as lipase inhibitors |
| 06/03/2004 | CA2506704A1 Peritoneal dialysis method |
| 06/03/2004 | CA2506397A1 Method and apparatus for the detection and occlusion of blood vessels |
| 06/03/2004 | CA2506308A1 Combination administration of an indolinone with a chemotherapeutic agent for cell proliferation disorders |
| 06/03/2004 | CA2506129A1 2'-branched nucleosides and flaviviridae mutation |
| 06/03/2004 | CA2506085A1 Combination chemotherapy comprising a mek inhibitor and capecitabine for treating cancer |
| 06/03/2004 | CA2505717A1 Use of multi-specific, non-covalent complexes for targeted delivery of therapeutics |
| 06/03/2004 | CA2505377A1 Combination cancer therapy with a gst-activated anticancer compound and another anticancer therapy |
| 06/03/2004 | CA2505167A1 Gastrin compositions and formulations, and methods of use and preparation |
| 06/03/2004 | CA2504250A1 Use of selective progesterone receptor modulators for the treatment of androgen deficiency |
| 06/03/2004 | CA2503316A1 Method and compositions for temporarily incapacitating subjects |
| 06/03/2004 | CA2503312A1 Method and compositions for treating persistent pulmonary hypertension using aralkyl ester soft drugs |
| 06/02/2004 | EP1424080A1 Gnrh agonist combination drugs |
| 06/02/2004 | EP1424079A1 Combination of a beta-3-receptor agonist and of a reuptake inhibitor of serotonin and/or norepinephrine |
| 06/02/2004 | EP1424071A1 Perfume compositions |